beryllium 2-sulfooxybenzoate
|
|
Canonical SMILES:
[Be+2].C1=CC=C(C(=C1)C(=O)[O-])OS(=O)(=O)O.C1=CC=C(C(=C1)C(=O)[O-])OS(=O)(=O)O
Isomeric SMILES
[Be+2].C1=CC=C(C(=C1)C(=O)[O-])OS(=O)(=O)O.C1=CC=C(C(=C1)C(=O)[O-])OS(=O)(=O)O
InChI
InChI=1S/2C7H6O6S.Be/c2*8-7(9)5-3-1-2-4-6(5)13-14(10,11)12;/h2*1-4H,(H,8,9)(H,10,11,12);/q;;+2/p-2
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- (8S,9S,10S,13S,14S,17R)-17-ethynyl-10-fluoranyl-13-methyl-17-oxidanyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-3-one
- (8S,9R,10S,13S,14S,17S)-9-fluoranyl-10,13-dimethyl-17-(2-oxidanylethanoyl)-2,6,7,8,11,12,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-one
- 2,3,4,5,7,8,9,9a-octahydro-1H-pyrrolo[1,2-a][1,4]diazepine; guanidine
- 1,2,3,4,5,7,8,9,10,10a-decahydropyrido[1,2-a][1,4]diazepine; guanidine
- (4aR,4bS,6aS,6bR,7S,10aR,11aS,11bR)-6b-ethanoyl-4a,6a,7-trimethyl-4,4b,5,6,7,8,9,10,10a,11,11a,11b,12,13-tetradecahydro-3H-indeno[2,1-a]phenanthren-2-one
- N-[2-(dimethylamino)ethanoyl]-4-[(3-methyl-2-nitro-imidazol-4-yl)methoxy]benzeneamine oxide
- 2-azanyl-1-methyl-5,8-dihydropteridin-4-one
- 2-(dimethylamino)-N-[4-[(3-methyl-2-nitro-imidazol-4-yl)methoxy]phenyl]-N-oxidanidyl-ethanamide
- (2S)-1-[(2S)-2-acetamidopropanoyl]-N-[1,1,1-tris(fluoranyl)-4-methyl-2-oxidanylidene-pentan-3-yl]pyrrolidine-2-carboxamide
- (2S,3S,4S,5R)-6-[(2R,3S,4R,5R)-5-acetamido-2-(hydroxymethyl)-3,6-bis(oxidanyl)oxan-4-yl]oxy-3,4,5-tris(oxidanyl)oxane-2-carboxylic acid

